iifl-logo-icon 1

Healthcare Global Enterprises Ltd Share Price

441.25
(-1.22%)
Oct 9, 2024|03:32:18 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open447.05
  • Day's High450
  • 52 Wk High454
  • Prev. Close446.7
  • Day's Low440
  • 52 Wk Low 314
  • Turnover (lac)594.29
  • P/E149.13
  • Face Value10
  • Book Value86.12
  • EPS2.99
  • Mkt. Cap (Cr.)6,150.44
  • Div. Yield0
View All Historical Data
No Records Found

Healthcare Global Enterprises Ltd KEY RATIOS

Sector

Healthcare

Open

447.05

Prev. Close

446.7

Turnover(Lac.)

594.29

Day's High

450

Day's Low

440

52 Week's High

454

52 Week's Low

314

Book Value

86.12

Face Value

10

Mkt Cap (₹ Cr.)

6,150.44

P/E

149.13

EPS

2.99

Divi. Yield

0

Healthcare Global Enterprises Ltd Corporate Action

25 Jul 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

5 Sep 2024

12:00 AM

AGM

Announcement Date: 05 Sep, 2024

arrow

Healthcare Global Enterprises Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Healthcare Global Enterprises Ltd SHAREHOLDING SNAPSHOT

09 Oct, 2024|06:11 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 60.37%

Foreign: 60.37%

Indian: 10.87%

Non-Promoter- 14.84%

Institutions: 14.84%

Non-Institutions: 13.90%

Custodian: 0.00%

Share Price

Healthcare Global Enterprises Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

139.29

139.12

139.01

169.25

Preference Capital

0

0

0

0

Reserves

1,049.3

1,006.01

958.68

754.54

Net Worth

1,188.59

1,145.13

1,097.69

923.79

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Revenue

608.86

688.33

586.86

545.03

yoy growth (%)

-11.54

17.28

7.67

15.68

Raw materials

-138.45

-146.57

-155.15

-149.39

As % of sales

22.74

21.29

26.43

27.4

Employee costs

-136.72

-142.69

-115.58

-98.06

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

-51.96

-34.57

33.93

29.3

Depreciation

-86.57

-79.4

-43.92

-44.15

Tax paid

13.51

12.16

-11.98

-9.81

Working capital

242.78

-76.35

-42.48

40.7

Other operating items

View Cash Flow
Y/e 31 MarMar-2021Mar-2020Mar-2018Mar-2017

Growth matrix (%)

Revenue growth

-11.54

17.28

7.67

15.68

Op profit growth

-36.51

30.42

7.32

29.58

EBIT growth

-77.48

-20.26

34.27

49.42

Net profit growth

259.39

-314.13

27.74

-512.27

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

1,907.87

1,691.41

1,394.78

1,009.19

1,092.34

Excise Duty

0

0

0

0

0

Net Sales

1,907.87

1,691.41

1,394.78

1,009.19

1,092.34

Other Operating Income

4.25

3.03

3.01

4.25

3.3

Other Income

21.23

13.18

107.28

16.95

6.97

Healthcare Global Enterprises Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Apollo Hospitals Enterprise Ltd

APOLLOHOSP

6,924.3

9599,568.72251.70.231,936.6536.28

Max Healthcare Institute Ltd

MAXHEALTH

955.85

130.0793,062.2154.140.16621.3979.01

Fortis Healthcare Ltd

FORTIS

597.2

341.1745,074.7826.830.17333.4120.36

Syngene International Ltd

SYNGENE

876.95

78.4735,316.5873.90.14726.5104.14

Dr Lal Pathlabs Ltd

LALPATHLAB

3,572.4

72.1129,829.74122.90.5534.5227.31

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Healthcare Global Enterprises Ltd

Management

Register Office

Registrar Office

Executive Chairman

BASAVALINGA AJAIKUMAR SADASHIVAIAH

Nominee

Siddharth Patel

Executive Director

Anjali Ajaikumar Rossi

Independent Non Exe. Director

Geet Mathur

Independent Non Exe. Director

RAJAGOPALAN RAGHAVAN

Independent Non Exe. Director

Pradip M. Kanakia

Whole Time Director & CEO

Meghraj Arvindrao Gore

Nominee

AMIT SONI

Independent Non Exe. Director

Rajiv Maliwal

Company Sec. & Compli. Officer

SUNU MANUEL

Independent Director

Jeyandran Venugopal

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Reports by Healthcare Global Enterprises Ltd

Summary

Healthcare Global Enterprises Limited was originally incorporated as Curie Centre of Oncology Private Limited on March 12, 1998 at Bengaluru, Karnataka, India as a Private Limited Company. The name of the Company was changed to HealthCare Global Enterprises Private Limited on November 14, 2005. Thereafter, it was converted into a Public Limited Company and the name of the Company was changed to Healthcare Global Enterprises Limited on July 5, 2006.Presently, the Company is engaged in setting up and managing hospitals and medical diagnostic services including scientific testing and consultancy services in the pharmaceutical and medical sector. Under the HCG brand, the Company operates the largest cancer care network in India in terms of the total number of private cancer treatment centres licensed by the AERB. Under the Milann brand, it operates fertility centres. Milann fertility centres provide comprehensive reproductive medicine services, including assisted reproduction, gynaecological endoscopy and fertility preservation; and follow a multidisciplinary and technology-focused approach to diagnosis and treatment. The Milann network also operates on a model similar to our HCG network, wherein the various Milann fertility centres aim to provide medical services following established protocols with a focus on quality medical care across diagnosis and treatment. It provides comprehensive inpatient and outpatient treatments. Its key specialties include cardiology, neurology, orth
Read More

Company FAQs

What is the Healthcare Global Enterprises Ltd share price today?

The Healthcare Global Enterprises Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹441.25 today.

What is the Market Cap of Healthcare Global Enterprises Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Healthcare Global Enterprises Ltd is ₹6150.44 Cr. as of 09 Oct ‘24

What is the PE and PB ratio of Healthcare Global Enterprises Ltd?

The PE and PB ratios of Healthcare Global Enterprises Ltd is 149.13 and 5.23 as of 09 Oct ‘24

What is the 52 Week High and Low of Healthcare Global Enterprises Ltd?

The 52-week high/low is the highest and lowest price at which a Healthcare Global Enterprises Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Healthcare Global Enterprises Ltd is ₹314 and ₹454 as of 09 Oct ‘24

What is the CAGR of Healthcare Global Enterprises Ltd?

Healthcare Global Enterprises Ltd's CAGR for 5 Years at 33.59%, 3 Years at 22.35%, 1 Year at 23.26%, 6 Month at 19.68%, 3 Month at 19.45% and 1 Month at 10.94%.

What is the shareholding pattern of Healthcare Global Enterprises Ltd?

The shareholding pattern of Healthcare Global Enterprises Ltd is as follows:
Promoters - 71.25 %
Institutions - 14.84 %
Public - 13.90 %

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS

  • Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020
  • Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.
  • Pay 20% upfront margin of the transaction value to trade in cash market segment.
  • Investors may please refer to the Exchange’s Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.
  • Check your Securities / MF / Bonds in the consolidated account statement issued by NSDL/CDSL every month.
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day.” – Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp